Michael Asbach, DMSc, PA-C, Psych-CAQ

Diagnostic clarity between anhedonia and persistent depressive disorder is paramount in clinical practice to ensure effective and safe treatment for patients.

Richard Jackson, MD, and Micheal Asbach, DMSc, PA-C, provide their key takeaways from these studies and insights on how providers can assess the impact of of tardive dyskinesia (TD) in every visit.

Richard Jackson, MD, and Micheal Asbach, DMSc, PA-C, discuss the physical, psychological, and social impacts of of tardive dyskinesia (TD) and how it may affect a patient’s underlying conditions.

Richard Jackson, MD, and Micheal Asbach, DMSc, PA-C, discuss the impact of of tardive dyskinesia (TD) on a caregiver’s life and work, highlighting the need for clinicians to support all allies in their patient’s support network.

Richard Jackson, MD, and Micheal Asbach, DMSc, PA-C, provide an overview of tardive dyskinesia (TD) and highlight recent studies that assessed the burden of TD on patients.

AI is evolving and changing the landscape of medicine and psychiatry. Here’s how clinicians can understand AI’s potential for psychiatry as well as its limitations.

Psychiatry: a field of medicine that is constantly evolving.